8-KOther EventsExhibits & Filings

AMEREN CORP 8-K Report, Corporate Update (May 12, 2021)

Filed May 12, 2021For Securities:AEE

Summary

Ameren Corporation (AEE) announced on May 12, 2021, the establishment of an equity distribution program through a Sales Agreement with several agents. This program allows Ameren to offer and sell shares of its common stock, with an aggregate gross sales price of up to $750,000,000, over time. The program includes the possibility of entering into forward sale agreements, which could impact the timing and nature of cash proceeds received by the company. This facility provides Ameren with flexibility to access equity capital through "at the market" offerings, potentially capitalizing on favorable market conditions. While the company is not obligated to sell any shares, the agreement offers a mechanism for opportunistic financing. Investors should note that the ultimate cash proceeds and the timing of their receipt may vary depending on whether the company physically settles forward sale agreements or opts for cash or net share settlement.

Key Highlights

  • 1Ameren established an equity distribution program allowing for the sale of common stock up to an aggregate gross sales price of $750 million.
  • 2The program is structured with multiple financial institutions acting as sales agents and forward sellers/purchasers.
  • 3Sales can be conducted through "at the market" offerings on the NYSE or other eligible venues, or via privately negotiated transactions.
  • 4The agreement includes provisions for forward sale agreements, which allow the company to defer cash settlement.
  • 5The company has no obligation to sell any shares under the agreement and can suspend the program at any time.
  • 6Shares will be offered under Ameren's effective Form S-3 Registration Statement (No. 333-249475).
  • 7The forward sale price is subject to adjustments based on commissions, volume-weighted average price, and a floating interest rate factor.

Frequently Asked Questions

The primary purpose is to provide Ameren Corporation with a flexible mechanism to potentially raise capital by selling shares of its common stock in the open market, or through other agreed-upon methods, up to a maximum aggregate gross sales price of $750 million. This allows the company to opportunistically access equity financing.

Under forward sale agreements, Ameren can arrange for shares to be sold by intermediaries now, but the company receives the cash proceeds later upon settlement. This allows Ameren to defer cash receipt. The settlement price is subject to adjustments. Investors should understand that while shares are sold, the company's receipt of funds is delayed, and the final amount received can fluctuate.

No, Ameren has no obligation to offer or sell any common stock under the Sales Agreement. The company can also suspend offers at any time, providing significant flexibility.

If Ameren chooses to cash settle or net share settle a forward sale agreement instead of physically settling it (by issuing new shares), the company might not receive any proceeds. In a cash settlement, Ameren could potentially owe cash to the forward purchaser. In a net share settlement, Ameren would owe shares of common stock to the forward purchaser. These options present alternative ways to manage the obligations without issuing new shares or receiving cash.